Johns Hopkins University Selects Collexis Expert Profiling System as the Translational Research Platform for Over 2,800 Medical ResearchersJune 3, 2008
University Signs Subscription Agreement with Collexis after Successful Pilot Project
COLUMBIA, SC – JUNE 2, 2008 – Collexis Holdings Inc. (OTCBB: CLXS), a leading developer of high definition search and knowledge discovery software, announced today that Johns Hopkins University has become the next institution to sign onto Collexis Expertise Profiling System for their entire medical community. The Collexis system creates updated profiles of University researchers based on their publications, grants and/or other associated work. The Collexis Platform was previously adopted across the National Institute of Health and is expected to be fully integrated with BiomedExperts.com, the first pre-populated, scientific social network for life science researchers.
This agreement with Johns Hopkins will create a Clinical Translational Research Platform for the University’s more than 2,800 medical researchers to connect and share their expertise via an updating web interface. The agreement represents an expansion of Collexis’ 18 month relationship with Johns Hopkins University, and will include all researchers from the School of Medicine, School of Nursing and School of Public Health.
Under the new agreement, Collexis will use its proprietary Fingerprinting process to search text for ideas and concepts rather than keywords and create Collexis Fingerprints or conceptual maps. The Expert Profiles will be generated using the Collexis fingerprints of the researchers’ publications from a variety of sources. Profiles are then available to be viewed and searched by all researchers. The expert profiling solution for Johns Hopkins is based on Collexis biomedical highly disambiguated expert database, which is the basis for the life science social networking site www.biomedexperts.com with 1.5 million expert profiles from researchers and 20 million connections between scientists around the globe.
“Collexis’ Expert Profiling System fosters collaboration among University researchers, allowing them to leverage the information of their colleagues and work towards advancing medical discovery,” said Bill Kirkland, CEO of Collexis Holdings, Inc. Kirkland further explained, “We are looking forward to continuing our relationship with Johns Hopkins and offering expanded knowledge technology services.”
Collexis’ pilot with Johns Hopkins was a landmark project within research institutions since, at that time, there was not another University that had a real-time, continually updating, searchable researcher profile system. As a result of using Collexis technology, Johns Hopkins was able to improve and facilitate interdisciplinary teaming, researcher recruitment, performance retention and internal review.
In addition to Johns Hopkins, Collexis is bringing its innovative technology to other medical research organizations and universities world-wide, including: the Mayo Clinic Libraries; Dana-Farber Cancer Institute, the University of California, San Francisco; the University of South Carolina; Bristol-Myers Squibb; Lockheed Martin; World Health Organization, National Institutes of Health; and US Department of Defense.
About Collexis Holdings, Inc.
Collexis Holdings, Inc., a leading developer of high definition search and knowledge discovery software is headquartered in Columbia, South Carolina (USA) with major operations in Cincinnati, Ohio, Geldermalsen, the Netherlands and Cologne, Germany. Collexis now offers the world’s first pre-populated scientific social network for life science researchers, www.biomedexperts.com. Collexis’ proprietary technology builds conceptual profiles of text, called Fingerprints, from documents, Websites, emails and other digitized content and matches them with a comprehensive list of pre-defined “fingerprinted” concepts to make research results more relevant and efficient. This matching of concepts eliminates the ambiguity and lack of priority associated with word searches. The results are often described as “finding needles in many haystacks.” Through this novel approach, Collexis can build unique applications to search, index and aggregate information as well as prioritize, trend and predict data based on sources in multiple industries without the limitations of language or dialect. Collexis’ current clients in the public, private and academic sectors include the Mayo Clinic; Johns Hopkins University; Dana-Farber Cancer Institute, the University of California, San Francisco; the University of South Carolina; Erasmus University Library; Bristol-Myers Squibb; Lockheed Martin; the World Health Organization; Wellcome Trust; the National Institutes of Health; and the U.S. Department of Defense. Shares of Collexis common stock are traded under the symbol CLXS on the OTC Bulletin Board (OTC BB). For more information, visit www.collexis.com.
Some of the statements made in this press release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s current expectations and include known and unknown risks, uncertainties and other factors, many of which the company is unable to predict or control, that may cause the company’s actual results or performance to differ materially from any future results or performance expressed or implied by such forward-looking statements. These statements involve risks and uncertainties, including risks and uncertainties associated with the company’s collaboration with Johns Hopkins University. These risks and uncertainties are in addition to other factors detailed from time to time in the company’s filings with the SEC, including the section entitled “Risk Factors” in its transition report on Form 10-KSB for the period ended June 30, 2007, as amended. The company cautions investors that any forward-looking statements made by the company are not necessarily indicative of future performance. The company is not responsible for updating the information contained in this press release beyond the published date, or for changes made to this document by wire services or Internet services.